{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T12:13:46Z","timestamp":1780488826133,"version":"3.54.1"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.ijcard.2016.03.070","type":"journal-article","created":{"date-parts":[[2016,3,22]],"date-time":"2016-03-22T05:30:09Z","timestamp":1458624609000},"page":"214-222","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Outcomes with bioabsorbable vascular scaffolds versus everolimus eluting stents"],"prefix":"10.1016","volume":"212","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9485-0652","authenticated-orcid":false,"given":"Sripal","family":"Bangalore","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bora","family":"Toklu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak L.","family":"Bhatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2016.03.070_bb0005","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1161\/CIRCULATIONAHA.112.097014","article-title":"Short- and long-term outcomes with drug-eluting and bare-metal coronary stents: a mixed-treatment comparison analysis of 117 762 patient-years of follow-up from randomized trials","volume":"125","author":"Bangalore","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2016.03.070_bb0010","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.e5170","article-title":"Outcomes with various drug eluting or bare metal stents in patients with diabetes mellitus: mixed treatment comparison analysis of 22,844 patient years of follow-up from randomised trials","volume":"345","author":"Bangalore","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.ijcard.2016.03.070_bb0015","doi-asserted-by":"crossref","first-page":"f6625","DOI":"10.1136\/bmj.f6625","article-title":"Bare metal stents, durable polymer drug eluting stents, and biodegradable polymer drug eluting stents for coronary artery disease: mixed treatment comparison meta-analysis","volume":"347","author":"Bangalore","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.ijcard.2016.03.070_bb0020","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1161\/CIRCULATIONAHA.110.003210","article-title":"Stent thrombogenicity early in high-risk interventional settings is driven by stent design and deployment and protected by polymer-drug coatings","volume":"123","author":"Kolandaivelu","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2016.03.070_bb0025","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/j.jcin.2015.03.029","article-title":"Acute thrombogenicity of a durable polymer everolimus-eluting stent relative to contemporary drug-eluting stents with biodegradable polymer coatings assessed ex vivo in a swine shunt model","volume":"8","author":"Otsuka","year":"2015","journal-title":"JACC Cardiovasc. Interv."},{"key":"10.1016\/j.ijcard.2016.03.070_bb0030","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1016\/S0140-6736(08)60922-8","article-title":"Appropriate use of drug-eluting stents: balancing the reduction in restenosis with the concern of late thrombosis","volume":"371","author":"Bavry","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2016.03.070_bb0035","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(12)61021-6","article-title":"Examination of new drug-eluting stents\u2014top of the class!","volume":"380","author":"Bhatt","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2016.03.070_bb0040","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s00392-013-0615-9","article-title":"Coronary vasomotor abnormalities in patients with stable angina after successful stent implantation but without in-stent restenosis","volume":"103","author":"Ong","year":"2014","journal-title":"Clin. Res. Cardiol."},{"key":"10.1016\/j.ijcard.2016.03.070_bb0045","doi-asserted-by":"crossref","unstructured":"Higgins J, Green S. Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.0 ed: The Cochrane Collaboration 2008. www.cochrane-handbook.org. Accessed Dec 12, 2013.","DOI":"10.1002\/9780470712184"},{"key":"10.1016\/j.ijcard.2016.03.070_bb0050","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1161\/CIRCULATIONAHA.106.685313","article-title":"Clinical end points in coronary stent trials: a case for standardized definitions","volume":"115","author":"Cutlip","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2016.03.070_bb0055","first-page":"1896","article-title":"Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement","volume":"354","author":"Moher","year":"1999","journal-title":"Qual. Rep. Metaanal. Lancet"},{"key":"10.1016\/j.ijcard.2016.03.070_bb0060","first-page":"86","article-title":"Sbe24: Metan \u2014 an Alternative Meta-analysis Command","volume":"8","author":"Bradburn","year":"1998"},{"key":"10.1016\/j.ijcard.2016.03.070_bb0065","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control. Clin. Trials"},{"key":"10.1016\/j.ijcard.2016.03.070_bb0070","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"10.1016\/j.ijcard.2016.03.070_bb0075","series-title":"User Manual for Trial Sequential Analysis (TSA)","first-page":"1","author":"Thorlund","year":"2011"},{"key":"10.1016\/j.ijcard.2016.03.070_bb0080","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jclinepi.2007.03.013","article-title":"Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis","volume":"61","author":"Wetterslev","year":"2008","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.ijcard.2016.03.070_bb0085","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/1471-2288-9-86","article-title":"Estimating required information size by quantifying diversity in random-effects model meta-analyses","volume":"9","author":"Wetterslev","year":"2009","journal-title":"BMC Med. Res. Methodol."},{"key":"10.1016\/j.ijcard.2016.03.070_bb0090","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.jcin.2013.05.005","volume":"6","author":"Dangas","year":"2013","journal-title":"JACC Cardiovasc. Interv."},{"key":"10.1016\/j.ijcard.2016.03.070_bb0095","first-page":"509","article-title":"Considerably lower risk of stent thrombosis and restenosis in \u201cnew generation\u201d drug-eluting stents: a report from the nation wide complete Swedish Coronary Angiography and Angioplasty Registry (SCAAR) (Abstract)","volume":"32","author":"Sarno","year":"2011","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2016.03.070_bb0100","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1056\/NEJMoa1509038","article-title":"Everolimus-eluting bioresorbable scaffolds for coronary artery disease","volume":"373","author":"Ellis","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2016.03.070_bb0105","article-title":"Effect of intravascular ultrasound-guided vs angiography-guided everolimus-eluting stent implantation: the IVUS-XPL randomized clinical trial","volume":"1-9","author":"Hong","year":"2015","journal-title":"JAMA"},{"issue":"10018","key":"10.1016\/j.ijcard.2016.03.070_bb0110","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0140-6736(15)00979-4","article-title":"Everolimus-eluting bioresorbable vascular scaffolds versus everolimus-eluting metallic stents: a meta-analysis of randomised controlled trials","volume":"387","author":"Cassese","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2016.03.070_bb0115","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.ahj.2012.08.010","volume":"164","author":"Diletti","year":"2012","journal-title":"Am. Heart J."},{"key":"10.1016\/j.ijcard.2016.03.070_bb0120","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0140-6736(14)61455-0","volume":"385","author":"Serruys","year":"2015","journal-title":"Lancet"},{"issue":"21","key":"10.1016\/j.ijcard.2016.03.070_bb0125","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1016\/j.jacc.2015.09.054","article-title":"Bioresorbable vascular scaffolds versus metallic stents in patients with coronary artery disease: absorb China trial","volume":"66","author":"Gao","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"issue":"47","key":"10.1016\/j.ijcard.2016.03.070_bb0130","doi-asserted-by":"crossref","first-page":"3332","DOI":"10.1093\/eurheartj\/ehv435","article-title":"A randomized trial evaluating everolimus-eluting Absorb bioresorbable scaffolds vs. everolimus-eluting metallic stents in patients with coronary artery disease: ABSORB Japan","volume":"36","author":"Kimura","year":"2015","journal-title":"Eur. Heart J."},{"issue":"3","key":"10.1016\/j.ijcard.2016.03.070_bb0135","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1093\/eurheartj\/ehv500","article-title":"Everolimus-eluting bioresorbable stent vs. durable polymer everolimus-eluting metallic stent in patients with ST-segment elevation myocardial infarction: results of the randomized ABSORB ST-segment elevation myocardial infarction-TROFI II trial","volume":"37","author":"Sabate","year":"2016","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2016.03.070_bb0140","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1745-6215-15-9","article-title":"Comparison of everolimus-eluting and biolimus-eluting coronary stents with everolimus-eluting bioresorbable scaffold: study protocol of the randomized controlled EVERBIO II trial","volume":"15","author":"Arroyo","year":"2014","journal-title":"Trials"},{"key":"10.1016\/j.ijcard.2016.03.070_bb0145","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.jacc.2014.12.017","article-title":"Comparison of everolimus- and biolimus-eluting coronary stents with everolimus-eluting bioresorbable vascular scaffolds","volume":"65","author":"Puricel","year":"2015","journal-title":"J. Am. Coll. Cardiol."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527316304910?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527316304910?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T20:38:43Z","timestamp":1759091923000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527316304910"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":29,"alternative-id":["S0167527316304910"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2016.03.070","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Outcomes with bioabsorbable vascular scaffolds versus everolimus eluting stents","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2016.03.070","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}